Amgen (AMGN) Asset Utilization Ratio (2009 - 2026)

Amgen (AMGN) posted quarterly Asset Utilization Ratio of 0.41 for Q1 2026, up 7.94% year-over-year from 0.38 in Q1 2025, and little changed on a QoQ basis from 0.41 in Q4 2025.

Amgen (AMGN) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Amgen (AMGN) has reported Asset Utilization Ratio for 17 consecutive years, with 0.41 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 7.94% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.41 (up 7.94% YoY), while the FY2025 annual figure was 0.4, up 13.91% from the prior year.
  • Asset Utilization Ratio came in at 0.41 for Q1 2026 at Amgen, roughly flat from 0.41 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.45 in Q2 2022, with the low at 0.23 in Q2 2023.
  • Average Asset Utilization Ratio over 5 years is 0.35, with a median of 0.37 recorded in 2024.
  • Across the five-year window, Asset Utilization Ratio tumbled 49.31% in 2023 and jumped 58.2% in 2024, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.31 in 2022, then declined by 2.98% to 0.3 in 2023, then climbed by 21.79% to 0.37 in 2024, then gained by 11.17% to 0.41 in 2025, then decreased by 0.03% to 0.41 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.41, 0.41, and 0.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 0.63
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.48
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 0.46
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 0.50
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 0.50
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 0.41
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.52
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.12
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 0.34

Historic Data

Download Data
DateValue
Mar 31, 2026 0.41
Dec 31, 2025 0.41
Sep 30, 2025 0.40
Jun 30, 2025 0.39
Mar 31, 2025 0.38
Dec 31, 2024 0.37
Sep 30, 2024 0.36
Jun 30, 2024 0.34
Mar 31, 2024 0.31
Dec 31, 2023 0.30
Sep 30, 2023 0.23
Jun 30, 2023 0.23
Mar 31, 2023 0.26
Dec 31, 2022 0.31
Sep 30, 2022 0.43
Jun 30, 2022 0.45
Mar 31, 2022 0.44
Dec 31, 2021 0.41
Sep 30, 2021 0.41
Jun 30, 2021 0.41